Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma.
about
A Phase II study of Dovitinib in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma.Optimized approach for Ion Proton RNA sequencing reveals details of RNA splicing and editing features of the transcriptomeNovel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) TranslocationsNuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastoma.The impact of the MYB-NFIB fusion proto-oncogene in vivo.Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer.Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma.Adenoid cystic carcinoma: emerging role of translocations and gene fusionsDown-regulation of miR-125a-5p is associated with salivary adenoid cystic carcinoma progression via targeting p38/JNK/ERK signal pathway.MYB expression: Potential role in separating adenoid cystic carcinoma (ACC) from pleomorphic adenoma (PA).The Utilization of Formalin Fixed-Paraffin-Embedded Specimens in High Throughput Genomic Studies.Whole-Genome Sequencing of Salivary Gland Adenoid Cystic CarcinomaApplications of molecular testing in surgical pathology of the head and neck.Nuclear Factor I/B: A Master Regulator of Cell Differentiation with Paradoxical Roles in Cancer.The Spectrum of Triple-Negative Breast Disease: High- and Low-Grade Lesions.Human papillomavirus-related carcinoma with adenoid cystic-like features of the sinonasal tract: clinical and morphological characterization of six new cases.A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma.In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type.A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug.HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma.Recurrent MYB rearrangement in blastic plasmacytoid dendritic cell neoplasm.Editorial: Targeting MYB Oncogene Expression in Adenoid Cystic Carcinoma.Genomic imbalances and MYB fusion in synchronous bilateral adenoid cystic carcinoma and invasive lobular carcinoma of the breast.Predictors of Outcome in Adenoid Cystic Carcinoma of Salivary Glands: A Clinicopathologic Study With Correlation Between MYB Fusion and Protein Expression.O-Linked N-Acetylglucosamine (O-GlcNAc) Expression Levels Epigenetically Regulate Colon Cancer Tumorigenesis by Affecting the Cancer Stem Cell Compartment via Modulating Expression of Transcriptional Factor MYBL1.Mut2Vec: distributed representation of cancerous mutations.Personalized oncogenomic analysis of metastatic adenoid cystic carcinoma: using whole-genome sequencing to inform clinical decision-making.Transcriptomes define distinct subgroups of salivary gland adenoid cystic carcinoma with different driver mutations and outcomes.Genomics of mucoepidermoid and adenoid cystic carcinomas.Mutation analysis of the EGFR pathway genes, EGFR, RAS, PIK3CA, BRAF, and AKT1, in salivary gland adenoid cystic carcinoma.
P2860
Q30252721-879280F4-C148-41AA-A1F3-6AA1880748DBQ36359621-CC5CBE5F-EDE0-4021-A35A-37EDBA88DC6FQ36726987-5040BA83-29D3-43F6-912A-DD17D7066D3FQ37301799-C1467E81-5EAB-4B72-A2C9-3D98EA167DBBQ37362488-BF108237-4DEC-42CD-8727-20EFB7698A46Q37372455-0623D8BA-07BF-43FE-934A-4449DD38DD3EQ37649999-8D5B5071-5503-49BD-BF3D-8F861FCE7C84Q37662396-85FF9CE6-11F5-4757-9BD0-DABC70B6C953Q37732988-7F6A8EC1-20A6-4657-A837-F5D529DD370AQ38411834-52EA6C09-D1CE-4BD8-8496-0ADBC9F8D8E0Q38752220-8274DFEA-502B-4CED-9D14-217E74554461Q38910120-B80022C4-12C3-4A30-9E8F-3C581641B27CQ39070411-A213952C-B603-44D1-AD42-A6B9E2A7BD4EQ39360520-5784F8E0-8ACE-4ADC-BA7C-908F676845BFQ39453298-A60F2AAA-FEB7-4CF0-935E-7000E62E90AAQ40390616-BF212E6C-CE5C-49D2-ABE9-28CEB239825CQ40605505-ABA11FF0-B2EB-4694-8BBC-9087D3A5E1CBQ40866227-224CA284-3F81-4D4A-8EB0-952CF9FA3827Q41194627-36FB358F-AEFD-4F75-BD40-1AB13F3382D4Q42509150-8D621261-5977-4D00-951D-A9AD71DB0D64Q47391427-64ED8FBE-C3C0-4348-9173-EF79E7F83FABQ48307548-1362C375-856A-4144-9B47-55D51F1CD12DQ48361501-FF72758B-5AF7-47F4-A216-8CEA8ABF89ACQ49716898-86001F3A-1B01-4F43-BE5C-217AE3819C08Q50144412-83C86A6C-9182-49BC-8000-C714F676E931Q50884067-8CF6AB1C-DB4F-4BF0-A5F2-DCEE9062EDF7Q51185635-E784E0DF-77B1-49FC-96D9-F220ACE40B25Q52561814-CF4ABC9E-7720-4372-BB57-73BBFA336667Q52611827-B6E38354-FE5C-4A2F-8B15-7FBA7575B834Q52684155-EB0B9D9F-0F9B-4356-95D9-D4DC568553BDQ54963200-1DC4571F-ADB7-4E95-9CBE-8C74D3610174Q55004879-46DEA5FA-745D-4BC8-B2A0-5DA64D7A7F3D
P2860
Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Recurrent Fusions in MYB and M ...... land Adenoid Cystic Carcinoma.
@en
type
label
Recurrent Fusions in MYB and M ...... land Adenoid Cystic Carcinoma.
@en
prefLabel
Recurrent Fusions in MYB and M ...... land Adenoid Cystic Carcinoma.
@en
P2093
P2860
P1433
P1476
Recurrent Fusions in MYB and M ...... Gland Adenoid Cystic Carcinoma
@en
P2093
Candace A Frerich
Huining Kang
Kathryn J Brayer
P2860
P304
P356
10.1158/2159-8290.CD-15-0859
P50
P577
2015-12-02T00:00:00Z